Cargando…

Persistently high antibody responses after AS03-adjuvanted H1N1pdm09 vaccine: Dissecting the HA specific antibody response

Current influenza vaccines have a suboptimal effectiveness. The introduction of a novel A/H1N1 influenza virus in 2009 (H1N1pdm09) provided a unique opportunity to study the humoral response to the AS03-adjuvanted H1N1pdm09 vaccine and repeated annual vaccination with the homologous virus in subsequ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madsen, Anders, Jul-Larsen, Åsne, Trieu, Mai-Chi, Krammer, Florian, Cox, Rebecca J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016826/ https://www.ncbi.nlm.nih.gov/pubmed/33795694 http://dx.doi.org/10.1038/s41541-021-00308-5

Ejemplares similares

Antibody Responses to Influenza A/H1N1pdm09 Virus After Pandemic and Seasonal Influenza Vaccination in Healthcare Workers: A 5-Year Follow-up Study
por: Trieu, Mai-Chi, et al.
Publicado: (2019)

No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination
por: Madsen, Anders, et al.
Publicado: (2019)

Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains
por: Lartey, Sarah, et al.
Publicado: (2015)

Non‐neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system
por: Friel, Damien, et al.
Publicado: (2020)

Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers
por: Hansen, Lena, et al.
Publicado: (2021)

Functional and Binding H1N1pdm09-Specific Antibody Responses in Occasionally and Repeatedly Vaccinated Healthcare Workers: A Five-Year Study (2009-2014)
por: Amdam, Håkon, et al.
Publicado: (2021)

Serum anti-neuraminidase antibody responses in human influenza A(H1N1)pdm09 virus infections
por: Karunarathna, Herath M. T. K., et al.
Publicado: (2019)

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

Augmented CD4(+) T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years
por: Trieu, Mai-Chi, et al.
Publicado: (2018)

In-Depth Analysis of HA and NS1 Genes in A(H1N1)pdm09 Infected Patients
por: Caglioti, Claudia, et al.
Publicado: (2016)

Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns
por: Helmig, Rikke B., et al.
Publicado: (2015)

Publisher Correction: Augmented CD4(+) T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years
por: Trieu, Mai-Chi, et al.
Publicado: (2018)

Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial()
por: Yang, William H., et al.
Publicado: (2013)

Magnitude and Kinetics of T Cell and Antibody Responses During H1N1pdm09 Infection in Inbred Babraham Pigs and Outbred Pigs
por: Edmans, Matthew, et al.
Publicado: (2021)

Genetic diversity of HA1 domain of heammaglutinin gene of influenza A(H1N1)pdm09 in Tunisia
por: El Moussi, Awatef, et al.
Publicado: (2013)

Seroprevalence of Influenza A(H1N1)pdm09 Virus Antibody, England, 2010 and 2011
por: Hoschler, Katja, et al.
Publicado: (2012)

Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies
por: Gao, Jin, et al.
Publicado: (2019)

Immune Responses in Pigs Vaccinated with Adjuvanted and Non-Adjuvanted A(H1N1)pdm/09 Influenza Vaccines Used in Human Immunization Programmes
por: Lefevre, Eric A., et al.
Publicado: (2012)

Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection
por: Lu, Xiuhua, et al.
Publicado: (2022)

Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials
por: van der Most, Robbert G., et al.
Publicado: (2017)

Functional Balance between the Hemagglutinin and Neuraminidase of Influenza A(H1N1)pdm09 HA D222 Variants
por: Casalegno, Jean-Sébastien, et al.
Publicado: (2014)

Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses
por: Kotani, Osamu, et al.
Publicado: (2021)

Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies
por: Garcia-Sicilia, José, et al.
Publicado: (2015)

Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease
por: Kim, Jin Hyang, et al.
Publicado: (2016)

Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies
por: Yasuhara, Atsuhiro, et al.
Publicado: (2017)

The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination
por: Goll, Johannes B., et al.
Publicado: (2022)

Lessons Learned from Influenza A(H1N1)pdm09 Pandemic Response in Thailand
por: Ungchusak, Kumnuan, et al.
Publicado: (2012)

Innate and adaptive immune responses in patients with pandemic influenza A(H1N1)pdm09
por: Huang, Yu, et al.
Publicado: (2013)

Rapid research response to the 2009 A(H1N1)pdm09 influenza pandemic (Revised)
por: Keitel, Wendy A, et al.
Publicado: (2013)

Reassortant Influenza A(H1N1)pdm09 Virus in Elderly Woman, Denmark, January 2021
por: Nissen, Jakob N., et al.
Publicado: (2021)

Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals
por: Strengell, Mari, et al.
Publicado: (2012)

Effectiveness of MF59™ Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands
por: Wijnans, Leonoor, et al.
Publicado: (2013)

Imprinted Anti-Hemagglutinin and Anti-Neuraminidase Antibody Responses after Childhood Infections of A(H1N1) and A(H1N1)pdm09 Influenza Viruses
por: Daulagala, Pavithra, et al.
Publicado: (2023)

Influenza A(H1N1)pdm09 But Not A(H3N2) Virus Infection Induces Durable Seroprotection: Results From the Ha Nam Cohort( )
por: Hoa, Le Nguyen Minh, et al.
Publicado: (2020)

Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: Pooled analysis of 28 clinical trials
por: Vaughn, David W, et al.
Publicado: (2014)

Virological characterization of influenza H1N1pdm09 in Vietnam, 2010-2013
por: Nguyen, Hang K L, et al.
Publicado: (2015)

Influenza A(H1N1)pdm09 virus and asthma
por: Obuchi, Masatsugu, et al.
Publicado: (2013)

A (H1N1) pdm09 HA D222 variants associated with severity and mortality in patients during a second wave in Mexico
por: Vazquez-Perez, Joel A, et al.
Publicado: (2013)

Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses
por: Liu, Mi, et al.
Publicado: (2023)

Assessing antigenic drift and phylogeny of influenza A (H1N1) pdm09 virus in Kenya using HA1 sub-unit of the hemagglutinin gene
por: Opanda, Silvanos, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_te9vhi9p4h3nh1fkb49iuimo0o